期刊
WORLD JOURNAL OF EMERGENCY MEDICINE
卷 4, 期 3, 页码 169-174出版社
ZHEJIANG UNIV SCH MEDICINE
DOI: 10.5847/wjem.j.issn.1920-8642.2013.03.002
关键词
Acinetobacter baumannii; Acinetobacter genomospecies 3; Acinetobacter genomospecies 13TU; Difference
资金
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
BACKGROUND: The Acinetobacter baumannii group, including Acinetobacter baumannii, Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology. This review aimed to demonstrate the differences among them. METHODS: Literatures associated with the Acinetobacter baumannii group were identified and selected from PubMed databases and relevant journals. RESULTS: Acinetobacter genospecies 3 and 13TU possess a certain proportion in clinical isolates. There were considerable differences in epidemiologic features, clinical manifestations, antimicrobial resistances and therapeutic options among the Acinetobacter baumannii group. Compared with Acinetobacter genomospecies 3 and 13TU, Acinetobacter baumannii with a higher resistance to antimicrobial agents are easier to be treated inappropriately, and present a worse outcome in patients. CONCLUSION: The Acinetobacter baumannii group comprises three distinct clinical entities, and their clinical value are not equal.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据